AHREFS
Ahrefs , a top-performing SEO software company, is pleased to announce major updates to its keyword data. The customers of the platform now have access to a 70% bigger database of international search queries, refined search volume accuracy, and a new proprietary SEO metric called “Traffic Potential.” With this boost, digital marketers and SEO professionals have more confidence to make content marketing decisions based on accurate and timely data.
Ahrefs uploaded 7.2 billion new keywords, increasing the total keyword database size from 10.1 billion to 17.3 billion keywords, which is a 70% increase. The coverage has been vastly improved across hundreds of countries, with some of them getting a 150-200% increase in database size.
With Ahrefs’ US database of 4.4 billion keywords – 69% larger than that of its main competitors – customers now have vastly greater coverage and can find more keyword ideas. They’ll also see a distinct search volume for each keyword, made possible by Ahrefs’ unique algorithm for modeling keyword search volumes that blends data from multiple sources, including clickstream. To fix the industry blunder of estimating search traffic potential based on the search volume of a single keyword, Traffic Potential shows how much total search traffic the top-ranking pages get from all the keywords they rank for.
Ahrefs Chief Marketing Officer Tim Soulo said, “We know 90% of content gets no traffic from Google while most U.S. businesses are highly ROI-oriented. So we want our users to stand out from the majority and feel confident their content marketing efforts can bring them visitors from search engines. Using Ahrefs’ toolset, users can find ideas that are ‘low-hanging fruits’ and create content which would bring them lots of customers.”
The updates fit seamlessly into Ahrefs’ Keywords Explorer , a tool that provides data on what people around the globe are searching for. Using it, marketers can discover thousands of keyword ideas, analyze their ranking difficulty, and calculate their traffic potential. Ahrefs updates the keyword database monthly and adds millions of new keywords each time. Keywords Explorer is the most complete keyword research tool on the market.
About Ahrefs
Ahrefs is a Singapore-based SEO software company that helps optimize websites of any scale — from giants like Netflix, Facebook, Uber, and Forbes to small businesses looking to build their presence on Google’s top page. According to The Straits Times, Ahrefs is one of Singapore’s fastest-growing companies in 2022. TechRadar also named Ahrefs one of the top five best online marketing service in 2022, along with Google Ads, Facebook, Hubspot, and Mailchimp.
To learn more about how Keywords Explorer can grow your business’s online visibility, visit Ahrefs’ website .
View source version on businesswire.com: https://www.businesswire.com/news/home/20220215005788/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
A-CAP Announces Successful Divestiture of Standard de Liège SA and Immobilière du Standard de Liège SRL6.6.2025 22:32:00 CEST | Press release
Successful Transaction Marks Another Milestone in A-CAP’s Soccer Club Portfolio Strategy Advantage Capital Holdings, LLC (“A-CAP” or “The Company”), a New York-based insurance and financial services company with over $12 billion in assets, today announced the successful divestiture of Standard de Liège SA (“Standard Liège” or the “Club”), one of Belgium's most historic soccer clubs, and Immobilière du Standard de Liège SRL, the corporate entity that owns the Club's stadium, Maurice Dufrasne Stadium, to a consortium of buyers led by Standard Liège Chief Executive Officer Giacomo Angelini. This transaction marks the end of 777 Partners’ legacy involvement with the Club and sets the stage for the Club’s future growth and success, both on and off the field. Benefits of the transaction include: Increased stability across the Club’s shareholder base, which clears the path for future investments, Operational clarity, establishing a unified direction that will allow both players and management
Populous Acquires Fentress Architects, Expanding Global Aviation Portfolio6.6.2025 20:00:00 CEST | Press release
Populous, the world-renowned design firm specializing in sport and entertainment venues, today announced the acquisition of Denver-based Fentress Architects, a global leader in iconic aviation projects and prominent public buildings, including convention centers, museums and government facilities. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250606849000/en/ Los Angeles International Airport. Designed by Fentress Architects. This strategic acquisition unites two of the most respected names in architecture, combining Populous’ unparalleled expertise in designing memorable experiences with Fentress’ award-winning portfolio of aviation, civic and cultural landmarks. The acquisition significantly broadens the scope and scale of services that Populous can offer clients across the globe. Bruce Miller, Populous Global Chair and CEO, commented: “We are committed to expanding the breadth of our practice. Fentress Architects has lon
Vertex Presents New Data on Benefits of ALYFTREK® and Importance of Achieving Lower Sweat Chloride Levels at the European Cystic Fibrosis Conference6.6.2025 18:00:00 CEST | Press release
- Oral presentation on outcomes following treatment with CFTR modulators show that improvements in CFTR function, as measured by lower sweat chloride, correlate with better outcomes for people with cystic fibrosis - - Oral presentation on new post hoc data from randomized, controlled and open-label trials suggest improved quality of life results with ALYFTREK compared to TRIKAFTA® – Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data across multiple studies demonstrating positive clinical and quality of life benefits of treatment with CFTR modulators and, in particular, ALYFTREK® (vanzacaftor/tezacaftor/deutivacaftor), which is approved in the United States and United Kingdom and is currently under review with health authorities in the EU, Canada, Australia, New Zealand and Switzerland. These data were presented at this year’s European Cystic Fibrosis Society’s (ECFS) 48th European Cystic Fibrosis Conference held June 4-7, 2025, in Milan, Italy. During the conferenc
Andersen Consulting tilføjer dimension med David and Golyat6.6.2025 16:33:00 CEST | Pressemeddelelse
Andersen Consulting udbygger sin globale konsulentkapacitet gennem en samarbejdsaftale med David and Golyat, en filippinsk konsulentvirksomhed inden for digital strategi. Med et stærkt fokus på business intelligence, kundeindsigt og digital first-eksekvering arbejder David and Golyat med kunder på tværs af flere sektorer – herunder regeringer, udviklingsorganisationer og private virksomheder – for at skabe langsigtet værdi gennem datainformerede beslutninger. Miko David, administrerende partner i David and Golyat, siger: "Vi ser frem til samarbejdet med Andersen Consulting, da det er en milepæl i vores vækstforløb. Ved at kombinere vores ekspertise inden for digital strategi og Andersen Consultings globale platform er vi i stand til at levere endnu større værdi til kunder, der navigerer på komplekse markeder." "Dette samarbejde betyder, at vi kan tilføre en ekstra dimension til vores globale konsulentplatform," siger Mark L. Vorsatz, global bestyrelsesformand og administrerende direktø
IBSA Derma at IMCAS Asia 2025: spotlight on the future of aesthetic medicine in the 10th Anniversary Year of NAHYCO® Technology6.6.2025 16:00:00 CEST | Press release
IBSA Derma, the dermoaesthetic division of Swiss company IBSA, will participate in the 18th IMCAS Asia Congress in Bangkok, gathering over 3,000 professionals from across the region to explore the future of aesthetic and regenerative medicine.With the presence in the Congress and a dedicated scientific symposium, the company reaffirms its commitment to advancing bioremodeling approaches and promoting a holistic, science-driven vision of authentic beauty.This year marks a key milestone for IBSA Derma: 10 years of NAHYCO® Technology, a patented innovation in hyaluronic acid science that continues to shape the future of tissue regeneration. IBSA Derma – the dermoaesthetic division of IBSA – once again confirms its leadership in the international aesthetic medicine landscape by participating in the 18th edition of IMCAS Asia, taking place from June 6 to 8 in Bangkok, Thailand. With over 3,000 attendees expected, the event represents a key opportunity for physicians and experts to share the
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom